Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised c...

por Ali, Shaukat, Luxmi, Shobha, Anjum, Fatima, Muhaymin, Sheikh Muhammad, Uddin, Syed Muneeb, Ali, Ayesha, Ali, Mir Rashid, Tauheed, Sohaib, Khan, Mujtaba, Bajwa, Mohsin, Baig, Saif Ullah, Shalim, Elisha, Ahmed, Iqra, Khan, Abdul Samad, Quraishy, Saeed
Publicado 2020

Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial

por Ali, Shaukat, Shalim, Elisha, Farhan, Farah, Anjum, Fatima, Ali, Ayesha, Uddin, Syed Muneeb, Shahab, Faisal, Haider, Mustafa, Ahmed, Iqra, Ali, Mir Rashid, Khan, Sadaf, Rao, Sadia, Guriro, Kabeer, Elahi, Saud, Ali, Muhammad, Mushtaq, Tehreem, Sayeed, Muneeba Ahsan, Muhaymin, Sheikh Muhammad, Luxmi, Shoba, Saifullah, Qureshi, Saeed
Publicado 2022

Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

por Ali, Shaukat, Uddin, Syed Muneeb, Shalim, Elisha, Sayeed, Muneeba Ahsan, Anjum, Fatima, Saleem, Farah, Muhaymin, Sheikh Muhammad, Ali, Ayesha, Ali, Mir Rashid, Ahmed, Iqra, Mushtaq, Tehreem, Khan, Sadaf, Shahab, Faisal, Luxmi, Shobha, Kumar, Suneel, Arain, Habiba, Khan, Mujtaba, Khan, Abdul Samad, Mehmood, Hamid, Rasheed, Abdur, Jahangeer, Ashraf, Baig, SaifUllah, Quraishy, Saeed
Publicado 2021